Genetic aspects of the etiology and treatment of asthma. Pediatr Clin North Am 2006 Aug;53(4):715-25
Date
07/29/2006Pubmed ID
16873001DOI
10.1016/j.pcl.2006.05.002Scopus ID
2-s2.0-33746209002 (requires institutional sign-in at Scopus site) 9 CitationsAbstract
This article provides a clinical review of the genetic aspects of the etiology and treatment of asthma for pediatric practitioners who are experienced in asthma diagnosis and management but lack expertise in genetics and immunology. Asthma is caused by the interaction of genetic susceptibility with environmental factors. The asthmatic response is characterized by elevated production of IgE, cytokines, and chemokines; mucus hypersecretion; airway obstruction; eosinophilia; and enhanced airway hyperreactivity to spasmogens. The genes most clearly associated with asthma include disintegrin and metalloprotease ADAM-33, dipeptidyl peptidase 10, PHD finger protein 11, and the prostanoid DP1 receptor. Within a few years, practitioners may apply sophisticated knowledge of cell and molecular biology to expand pharmacotherapeutic approaches and to personalize diagnosis and management.
Author List
Meurer JR, Lustig JV, Jacob HJAuthor
John R. Meurer MBA, MD Emeritus Professor in the Institute for Health and Humanity department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AsthmaChild
Genetic Predisposition to Disease
Humans
Pharmacogenetics
Pulmonary Disease, Chronic Obstructive
